Alex Goldberg

NASDAQ Gainers Watch List: Akorn, Inc. (NASDAQ:AKRX) and NVIDIA Corporation (NASDAQ:NVDA) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/24/2014 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Akorn, Inc. (NASDAQ:AKRX) and NVIDIA Corporation (NASDAQ:NVDA).

Akorn, Inc. (NASDAQ:AKRX) a company that manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals products, hospital drugs, and injectable pharmaceuticals in the United States and internationally is currently up (+4.91%) on 1,666,757 shares traded as Akorn, Inc. will host a conference call on Monday, March 3, 2014, to discuss fourth quarter 2013 results followed by a Q&A session. Akorn, Inc. (NASDAQ:AKRX) is currently up (+123.84%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Akorn, Inc. (NASDAQ:AKRX)

NVIDIA Corporation (NASDAQ:NVDA) a visual computing company that develops graphics chips for use in personal computers, mobile devices, and supercomputers is currently up (+1.64%) on 7,546,549 shares traded. NVIDIA Corporation (NASDAQ:NVDA) is currently up (+58.22%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about NVIDIA Corporation (NASDAQ:NVDA)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com